Measuring Practice Pattern Changes and Clinical Utility of a Novel Test for Preeclampsia

NACompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

November 22, 2019

Primary Completion Date

December 23, 2019

Study Completion Date

December 23, 2019

Conditions
Pre-Eclampsia
Interventions
OTHER

Experimental Arm

"* First, these providers will receive educational materials (e.g. a slide deck) meant to mimic what physicians will receive in the real-world market as they learn about the Progenity technology.~* Second, within each of their four cases, intervention-arm physicians only will receive simulated test results from the Progenity PE test at the clinically-appropriate point in each case."

Trial Locations (1)

94109

QURE Healthcare, San Francisco

All Listed Sponsors
collaborator

Progenity, Inc.

INDUSTRY

lead

Qure Healthcare, LLC

INDUSTRY

NCT04204018 - Measuring Practice Pattern Changes and Clinical Utility of a Novel Test for Preeclampsia | Biotech Hunter | Biotech Hunter